0001209191-15-059095.txt : 20150702 0001209191-15-059095.hdr.sgml : 20150702 20150702180939 ACCESSION NUMBER: 0001209191-15-059095 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150630 FILED AS OF DATE: 20150702 DATE AS OF CHANGE: 20150702 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Paratek Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001178711 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330960223 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 75 KNEELAND STREET STREET 2: 6TH FLOOR CITY: BOSTON STATE: MA ZIP: 02111 BUSINESS PHONE: (617) 275-0040 MAIL ADDRESS: STREET 1: 75 KNEELAND STREET STREET 2: 6TH FLOOR CITY: BOSTON STATE: MA ZIP: 02111 FORMER COMPANY: FORMER CONFORMED NAME: Transcept Pharmaceuticals Inc DATE OF NAME CHANGE: 20090130 FORMER COMPANY: FORMER CONFORMED NAME: NOVACEA INC DATE OF NAME CHANGE: 20020724 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Haskel William M. CENTRAL INDEX KEY: 0001524372 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36066 FILM NUMBER: 15971391 MAIL ADDRESS: STREET 1: ONE MEADOWLANDS PLAZA CITY: EAST RUTHERFORD STATE: NJ ZIP: 07073 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-06-30 0 0001178711 Paratek Pharmaceuticals, Inc. PRTK 0001524372 Haskel William M. C/O PARATEK 75 KNEELAND STREET, 6TH FLOOR BOSTON MA 02111 0 1 0 0 Sr. VP, Sec. & General Counsel Common Stock 2015-06-30 4 A 0 20000 0.00 A 21000 D Stock Option (right to buy) 25.77 2015-06-30 4 A 0 130000 0.00 A 2025-06-29 Common Stock 130000 130000 D The exercise price is equal to the closing sales price per share of Common Stock as reported on The Nasdaq Global Market on the date of grant. The shares shall vest as follows: 32,500 shares (25%) shall vest on June 29, 2016; and the remaining 97,500 (75%) shares shall vest in monthly installments of 2,708 shares (1/36th) on a monthly basis thereafter. /s/ William M. Haskel 2015-07-02